NCT01879488

Brief Summary

Controlling the respiratory pattern of mechanically ventilated patients in volume control mode is recommended during nebulization. No studies looked into conditions of nebulization during assisted mechanical ventilation to define the optimal nebulization technique and its effect on pulmonary deposition. The aim of this study is to analyse the effect of ventilation mode (barometric versus volumetric) on deposition by planar scintigraphy during mechanical ventilation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 17, 2013

Completed
14 days until next milestone

Study Start

First participant enrolled

July 1, 2013

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

November 17, 2015

Status Verified

November 1, 2015

Enrollment Period

1.9 years

First QC Date

June 10, 2013

Last Update Submit

November 16, 2015

Conditions

Keywords

AerosolLung depositionMechanical ventilation

Outcome Measures

Primary Outcomes (1)

  • Pulmonary deposition

    Immediately after nebulization by imaging assessment, an expected average of 30 minutes

Secondary Outcomes (3)

  • Penetration index

    Immediately after nebulization by imaging assessment, an expected average of 30 minutes

  • Mechanical ventilation settings

    During nebulisation time, an expected average of 15 minutes

  • Lung function

    Preoperative assessment, the day before inclusion

Study Arms (2)

Nebulization during pressure support ventilation

ACTIVE COMPARATOR

Patients ventilated in pressure support mode during nebulization

Drug: technetium-99m - Diethylenetriaminepentaacetic acidDevice: Vibrating-mesh nebulizerOther: Gamma scintigraphyOther: Preoperative spirometry

Nebulization during volume assist control mode

ACTIVE COMPARATOR

Patients ventilated in volume assist control mode during nebulization

Drug: technetium-99m - Diethylenetriaminepentaacetic acidDevice: Vibrating-mesh nebulizerOther: Gamma scintigraphyOther: Preoperative spirometry

Interventions

Nebulization during pressure support ventilationNebulization during volume assist control mode
Nebulization during pressure support ventilationNebulization during volume assist control mode
Nebulization during pressure support ventilationNebulization during volume assist control mode
Nebulization during pressure support ventilationNebulization during volume assist control mode

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Invasive mechanical ventilation
  • Healthy lungs

You may not qualify if:

  • Change of ventilation mode during nebulization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cliniques Universitaires Saint-Luc

Brussels, 1200, Belgium

Location

Related Publications (1)

  • Dugernier J, Reychler G, Wittebole X, Roeseler J, Depoortere V, Sottiaux T, Michotte JB, Vanbever R, Dugernier T, Goffette P, Docquier MA, Raftopoulos C, Hantson P, Jamar F, Laterre PF. Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study. Ann Intensive Care. 2016 Dec;6(1):73. doi: 10.1186/s13613-016-0169-x. Epub 2016 Jul 22.

Study Officials

  • Pierre-François Laterre

    Head of Intensive Care Unit, Cliniques Universitaires Saint-Luc

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2013

First Posted

June 17, 2013

Study Start

July 1, 2013

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

November 17, 2015

Record last verified: 2015-11

Locations